AbbVie to Present at the UBS Global Healthcare Virtual Conference

Rhea-AI Summary

AbbVie will participate in the UBS Global Healthcare Virtual Conference on May 25, 2021, at 11:00 a.m. Central time. Key executives participating include Michael Severino, Robert A. Michael, and Jeffrey R. Stewart. A live audio webcast will be available on AbbVie’s Investor Relations website, with an archived version accessible later the same day. AbbVie is dedicated to developing innovative medicines across various therapeutic areas such as immunology, oncology, and neuroscience.

News Market Reaction – ABBV

+1.09%

+1.09% Session move

In the trading session that priced this news, ABBV gained 1.09%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH CHICAGO, Ill., May 20, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 11:00 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

 

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-ubs-global-healthcare-virtual-conference-301295596.html

SOURCE AbbVie

FAQ

What is AbbVie's participation in the UBS Global Healthcare Virtual Conference 2021?

AbbVie will present at the UBS Global Healthcare Virtual Conference on May 25, 2021, at 11:00 a.m. Central time.

Who from AbbVie will present at the UBS conference?

Michael Severino, Robert A. Michael, and Jeffrey R. Stewart will be presenting.

Where can I listen to the AbbVie conference presentation?

The presentation will be available via a live audio webcast on AbbVie's Investor Relations website.

Will there be a recording of the AbbVie conference session?

Yes, an archived edition of the session will be available later on the same day.

What are AbbVie's key therapeutic areas?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.